Uber-Charged: The DOJ, Uber’s “Wait Time Fee”, and Some Pricing Common Sense
Legitimate Pricing Strategy, Poor Execution? The Department of Justice has sued Uber for charging “wait time” fees to passengers who, because of disability, need more time to enter a car. The lawsuit alleges that Uber “violates the ADA by failing to reasonably modify its wait time fee policy for passengers who, because of disability, need more […]
Pruning Customers to Increase Profitability In A Supply-Constrained Environment
Many companies operate on the assumption that any customer providing “some” additional contribution margin is a good customer. Surely having it is better than the alternative, they reason. This week, FedEx disagreed. It didn’t just let go 1,400 customers, but made it public. It put both customers and competitors on notice that severe supply constraints […]
Pharmaceutical Company AbbVie Inflated Prices for Two Major Drugs, House Oversight Report Says
Pharmaceutical company AbbVie significantly inflated prices over the past two decades for patients in the U.S. who take the drugs Humira and Imbruvica, a report released Tuesday by the House Oversight and Reform Committee found. Read the full article Photo Credits: AbbVie
With Costs on the Rise, Should You Raise Your Prices?
By the big numbers, eCommerce has been flying high during the pandemic. Online sales have soared, as homebound and restless consumers shopped online in greater numbers than ever before. Read the full article Photo Credits: Unsplash/sutirta budiman
The Broader Lesson from Booming Copper Prices
Blessed are the cheesemakers. A revival in restaurant visits in America has fed demand for one of the more obscure financial instruments—cheese futures. The number of contracts traded on the Chicago Mercantile Exchange surged last month. It is not only cheese that has melted up. Read the full article Photo Credits: Unsplash/Ra Dragon
AbbVie CEO Summoned to Congress—Again—to Answer Questions on Humira Pricing, Patenting
Accused of forming a patent thicket around its top-seller Humira and cancer blockbuster Imbruvica, AbbVie has faced repeated pressure from the House Committee on Oversight and Reform to layout its pricing and patenting strategies. With that information now in hand, the committee is putting AbbVie’s helmsman in the hot seat. Read the full article […]
